Cagent Vascular Announces Peer-Reviewed Study on Serration Remodeling Therapy™
Cagent Vascular has published a peer-reviewed study demonstrating the safety and efficacy of the Serranator® PTA Serration Balloon Catheter for treating pedal interventions in patients with chronic limb-threatening ischemia (CLTI), highlighting its effectiveness in challenging below-the-ankle arteries. The study was led by Dr. Edward Gifford and involved multiple institutions.
WAYNE, Pa.–(BUSINESS WIRE)– #CLI–Cagent Vascular, a leader in innovative endovascular technologies, today announced the publication of a peer-reviewed study in the Journal of Endovascular Therapy (JEVT) demonstrating the safety and efficacy of the Serranator® PTA Serration Balloon Catheter in pedal (inframalleolar) interventions for patients with chronic limb-threatening ischemia (CLTI). The investigator-initiated, multi-institutional, retrospective study, led by Dr. Edward Gifford, vascular surgeo